- Catching up
Our website has just soft-launched, so here’s some highlights from the Fall 2020 semester.
Kate’s new paper has been published! Kate found that people with variants in the gene encoding the structural protein titin have an increased risk of AF. You can read the abstract here.
Our collaboration with CHEOS, looking at the consensus on clinical management of AF patients receiving dialysis, was published. Read the abstract here.
Leili’s recent work was highlighted by Stemcell Technologies as some of their favourite science of the year!
Kate’s abstract for the Canadian Cardiovascular Society 2020 Congress was one of the top 10!
Zach was named runner-up for the 2020 Canadian Cardiovascular Society’s Young Investigator Award in Basic Science.
Kate and Mishal won First place for Rapid Fire Presentation and Second place for Poster Presentation, respectively, at the 2020 BC RegMed meeting,
Our collaboration with the Tibbits lab describing our drug screening platform was published, and you can read the abstract here.
pubmed
- Efficacy of Mavacamten Therapy Following Unsuccessful Septal Reduction in Obstructive Hypertrophic Cardiomyopathy: A Retrospective Analysis
- Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk
- Spatial Transcriptomics in Human Cardiac Tissue
- Atrial Fibrillation Related Titin Truncation Is Associated With Atrial Myopathy in Patient-Derived Induced Pluripotent Stem Cell Disease Models
- Polygenic Risk Score Implementation into Clinical Practice for Primary Prevention of Cardiometabolic Disease